IMV Inc., a Canadian pharmaceutical company, listed on both the TSX and Nasdaq, (TSX: IMV, Nasdaq: IMV) is making important advances in immunotherapy treatment. CEO, Frederic Ors states, “We have developed a new type of treatment for cancer, one…
Read More...
Browsing Category
Articles
Vext Science: Scaling Up for Adult Cannabis Use in Arizona
With Proposition 17 being passed in the state of Arizona, cannabis will move to an adult-use framework in 2021. Vext Science Inc.,…
Lion One Metals strikes gold
The Tuvatu Alkaline Gold Project is 100 percent owned and fully permitted. It sits on the island of Viti Levu, in the Republic of…
